Your browser doesn't support javascript.
loading
Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.
Li, Shuyi; Li, Chan; Jin, Shubin; Liu, Juan; Xue, Xiangdong; Eltahan, Ahmed Shaker; Sun, Jiadong; Tan, Jingjie; Dong, Jinchen; Liang, Xing-Jie.
Afiliação
  • Li S; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Li C; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Jin S; Beijing Municipal Institute of Labour Protection, No.55 Taoranting Road, Xicheng District, Beijing, 100054, PR China.
  • Liu J; Tissue Engineering Lab, Beijing Institute of Transfusion Medicine, Beijing, 1000850, PR China.
  • Xue X; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Eltahan AS; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Sun J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Tan J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Dong J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
  • Liang XJ; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, No.11, First North Road, Zhongguancun, Beijing,
Biomaterials ; 144: 119-129, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28834763
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Inibidores Enzimáticos / Ácido Etacrínico / Glutationa Transferase / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Inibidores Enzimáticos / Ácido Etacrínico / Glutationa Transferase / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article